<
 
 
 
 
>
hide
You are viewing a Web site, archived on 10:38:41 Nov 02, 2004. It is now a Federal record managed by the National Archives and Records Administration.
External links, forms, and search boxes may not function within this collection.
U.S. Food and Drug Administration, Bioengineered Foods
Under FDA policy developers of bioengineered foods are expected to consult with the agency before marketing, to ensure that all safety and regulatory questions have been fully addressed. FDA’s policy also requires special labeling for bioengineered foods under certain circumstances. For example, a bioengineered food would need to be called by a different or modified name if its composition were significantly different from its conventionally grown counterpart, or if its nutritive value has been significantly altered. Special labeling would be required if consumers need to be informed about a safety issue, such as the possible presence of an allergen that would not normally be found in the conventionally-grown product.

U.S. District Court Dismisses Genetically Engineered Food Law Suit Against FDA (Oct. 6, 2000)

FDA to Strengthen Pre-Market Review of Bioengineered Foods (May 3, 2000)

 

Public Meetings on Bioengineered Foods

FDA Announces Public Meetings on Bioengineered Foods
(Oct. 18, 1999, Press Release)

Biotechnology in the Year 2000 and Beyond; Public Meetings
(Oct. 25, 1999, Federal Register Notice)—PDF
or Text Version

Background Information

Are Bioengineered Foods Safe? (FDA Consumer article)

Genetic Engineering: Fast Forwarding to Future Foods (FDA Consumer article)

Biotechnology



FDA Home Page | Search | A-Z Index | Site Map | Contact FDA

FDA/Website Management Staff
Web page created by zwr. Last updated 22-JAN-2001.